Johnson & Johnson Medical China Launches New Customer Logistics Warehouse in Suzhou to Enhance Integrated Supply Chain

SUZHOU, China, Aug. 3, 2021 /PRNewswire/ -- Recently, Johnson & Johnson Medical China announced the establishment of a new customer logistics warehouse in Suzhou to accelerate the upgrade of its "integrated" supply chain, meeting the growing and evolving healthcare demands of the Chinese market. Located within Johnson & Johnson Medical's largest supply chain base in China -- the Johnson & Johnson Medical Suzhou Industrial Park, the new warehouse will expedite the delivery of locally innovated and locally manufactured medical products to the Chinese market through customized logistics and customer service solutions, thereby serving more patients and customers with greater agility and efficiency.

“This represents an exploration and innovation in our business model, embodying our Credo, and will create greater value for patients and physicians,” said Song Weiqun, Senior Vice President of Johnson & Johnson Worldwide and Chairman of the China Region. “The Chinese market holds immense growth potential. The public's diverse needs for high-quality healthcare services will continue to position China as a global innovation engine, while continuously injecting new momentum into Johnson & Johnson's development in China. Establishing a more closely interconnected end-to-end global supply chain in China represents a key strategic advantage for Johnson & Johnson in serving this market. By leveraging the integrated capabilities of the Johnson & Johnson Medical Suzhou Industrial Park, we will further accelerate the upgrading of local supply capacity, enabling us to respond to the healthcare needs of Chinese patients faster and more effectively, and contribute to the Healthy China initiative.”

In the post-pandemic new normal, the public has raised higher expectations for high-quality medical and healthcare services. Particularly with the rapid development of "Internet + Healthcare," market demand for personalized, differentiated, and convenient supply chain services continues to grow. Johnson & Johnson Medical continues to innovate in China and has pioneered a new model for optimizing customer service. By establishing leading customer logistics and service capabilities within the Johnson & Johnson Medical Suzhou Industrial Park, these functions are seamlessly integrated with other on-site supply chain operations, including innovative R&D, smart manufacturing facilities, and global procurement. This integration will significantly enhance supply efficiency and market responsiveness, further fulfilling Johnson & Johnson's steadfast commitment to serving patients better and faster.

Above: Johnson & Johnson Medical China's New Customer Logistics Warehouse Officially Opens in Suzhou

Innovation is the enduring core competitiveness that has sustained Johnson & Johnson’s mission to advance global health for over 130 years, and it has also served as the catalyst propelling the company’s rapid development in China for more than three decades. As a leader in the global healthcare industry, Johnson & Johnson remains committed to bringing globally innovative technologies, solutions, and advanced manufacturing expertise to China. Meanwhile, by actively enhancing local innovation and R&D capabilities, and continuously upgrading high-end smart manufacturing alongside an agile “end-to-end” supply chain system, the company is positioning the Chinese market as a global dual engine of “growth + innovation”.

Currently, Johnson & Johnson operates nine supply chain bases in China, spanning medical devices, pharmaceuticals, and consumer health. Among them, the Johnson & Johnson MedTech Suzhou Industrial Park is the company’s largest medical device campus in China. Integrating comprehensive operations such as R&D, manufacturing, technological innovation and collaboration, and shared services, it plays a pivotal role within the global supply chain network. In addition to manufacturing and supplying orthopedic and surgical products for global markets, the facility has successively launched and commercialized innovative products including orthopedic spinal implants, linear cutting staplers, endoscopic staplers, and the Mingjing Ultra-HD 4K Arthroscopic Imaging System, serving customers and patients across China. Looking ahead, Johnson & Johnson will continue to roll out a series of advanced medical devices. Driven by a localized, high-end smart manufacturing and supply chain ecosystem that is globally empowered and seamlessly integrated, the company will accelerate its momentum in advancing the "Healthy China" initiative.